CVS Health Co. (NYSE:CVS) Shares Sold by Heritage Investors Management Corp

Heritage Investors Management Corp cut its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,244 shares of the pharmacy operator’s stock after selling 1,822 shares during the period. Heritage Investors Management Corp’s holdings in CVS Health were worth $2,862,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CVS. Neumann Capital Management LLC increased its position in CVS Health by 3.4% during the 4th quarter. Neumann Capital Management LLC now owns 42,716 shares of the pharmacy operator’s stock worth $3,373,000 after purchasing an additional 1,400 shares during the period. Hills Bank & Trust Co raised its position in CVS Health by 1.3% in the fourth quarter. Hills Bank & Trust Co now owns 56,566 shares of the pharmacy operator’s stock worth $4,466,000 after acquiring an additional 749 shares in the last quarter. US Asset Management LLC acquired a new stake in CVS Health in the fourth quarter valued at $378,000. Wealthspire Advisors LLC increased its holdings in shares of CVS Health by 1.0% in the 4th quarter. Wealthspire Advisors LLC now owns 22,286 shares of the pharmacy operator’s stock valued at $1,760,000 after purchasing an additional 210 shares in the last quarter. Finally, E Fund Management Co. Ltd. grew its holdings in shares of CVS Health by 9.4% in the 4th quarter. E Fund Management Co. Ltd. now owns 3,658 shares of the pharmacy operator’s stock worth $289,000 after acquiring an additional 313 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE CVS traded up $0.76 on Thursday, reaching $55.67. The company’s stock had a trading volume of 10,298,162 shares, compared to its average volume of 11,874,933. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The stock has a market cap of $69.89 billion, a PE ratio of 9.79, a PEG ratio of 0.88 and a beta of 0.56. CVS Health Co. has a twelve month low of $53.70 and a twelve month high of $83.25. The firm’s 50 day moving average is $71.54 and its two-hundred day moving average is $72.96.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same period in the prior year, the company posted $2.20 earnings per share. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, sell-side analysts predict that CVS Health Co. will post 7.03 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.78%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. The Goldman Sachs Group decreased their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Mizuho dropped their target price on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. SVB Leerink reiterated a “market perform” rating and issued a $60.00 price target (down from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Finally, Royal Bank of Canada lowered their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Nine research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $76.75.

Insider Transactions at CVS Health

In other news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.